Skip to main content
Clinical Trials/NCT04721145
NCT04721145CompletedNot Applicable

IMPaCT: IMPlementing Continuous Glucose Monitoring in High-risk, Poorly Controlled Children With Type 1 Diabetes

Johns Hopkins University1 site in 1 country26 target enrollmentStarted: January 25, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
26
Locations
1
Primary Endpoint
Change in Personal CGM Use

Study Overview

Brief Summary

The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
5 Years to 21 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of Type 1 diabetes for >3 months

Exclusion Criteria

  • CGM use in the last 6 months

Arms & Interventions

Dexcom G6 Continuous Glucose Monitor

Experimental

Children with type 1 diabetes will wear a continuous glucose monitor (CGM) for 10 days.

Intervention: Dexcom G6 Continuous Glucose Monitor (Device)

Outcomes

Primary Outcomes

Change in Personal CGM Use

Time Frame: Baseline and 3 months

Evaluate whether there is any change in uptake of personal CGM after 10-day trial.

Secondary Outcomes

  • Change in Hemoglobin A1c(Baseline, 3-6 months)
  • Using Personal CGM(3-6 months)
  • Change in the Percent Time in Range Glucose Control(1-5 days and 6-10 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials